| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Neuroradiology |
1 From the Department of Neurosurgery, Neurocenter, University of Erlangen-Nuremberg, Erlangen, Germany. Received November 8, 2004; revision requested January 5, 2005; revision received February 11; accepted March 7; final version accepted April 5. A.S. supported by the German Research Society (DFG Ga 638/2-1). S.G. supported by the Austrian Science Fund (FWF P14715-PSY). Address correspondence to E.M., MR Center of Excellence, Medical University of Vienna, Lazarettgasse 14, A-1090 Vienna, Austria (e-mail: ewald.moser{at}meduniwien.ac.at).
Purpose: To evaluate proton magnetic resonance (MR) spectroscopic imaging with high spatial resolution for preoperative grading of suspected World Health Organization grades II and III gliomas.
Materials and Methods: Institutional ethics committee approval and informed consent were obtained for control subjects but were not required for the retrospective component involving patients. Twenty-six patients (10 women, 16 men; mean age, 37.5 years) suspected of having gliomas and 26 age- and sex-matched control subjects underwent proton MR spectroscopy. Absolute metabolite concentrations for choline-containing compounds (Cho), creatine (Cr), and N-acetylaspartate (NAA)–N-acetylaspartylglutamate (total NAA [tNAA]) were calculated by using a user-independent spectral fit program. Metabolic maps of Cho/tNAA ratios were calculated, segmented, and used for MR spectroszpcopy–guided stereotactic brain biopsy. Two-sided paired Student t tests were used to test for statistical significance.
Results: Significantly lower Cho levels (P = .002) and higher tNAA levels (P = .010) were found in grade II tumors (n = 9) compared with grade III tumors (n = 17). The average Cho/tNAA ratio over the voxels in the tumor center showed a distinct difference (P < .001) between grade II and III gliomas at a threshold of 0.8 (with ratios <0.8 for grade II). The maximum Cr concentration in the tumor showed a clear-cut threshold between grade III oligodendrogliomas and oligoastrocytomas (Cr level, <7 mmol/L) and grade III astrocytomas (Cr level, >7 mmol/L; P = .020). Comparison between the histopathologic findings from the MR spectroscopy–guided biopsy samples (76 biopsies from 26 patients) and molar metabolite values in corresponding voxels located at the biopsy sampling points showed a negative linear correlation for tNAA (r = –0.905) and a positive exponential correlation for Cho (r = 0.769) and Cho/tNAA (r = 0.885).
Conclusion: Proton MR spectroscopic imaging with high spatial resolution allows preoperative grading of gliomas.
© RSNA, 2006
This article has been cited by other articles:
|
|
 |
|
  K. G. King, L. Glodzik, S. Liu, J. S. Babb, M. J. de Leon, and O. Gonen Anteroposterior Hippocampal Metabolic Heterogeneity: Three-dimensional Multivoxel Proton 1H MR Spectroscopic Imaging--Initial Findings Radiology, October 1, 2008; 249(1): 242 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Pichler, H. F. Wehrl, and M. S. Judenhofer Latest Advances in Molecular Imaging Instrumentation J. Nucl. Med., June 1, 2008; 49(Suppl_2): 5S - 23S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stadlbauer, O. Prante, C. Nimsky, E. Salomonowitz, M. Buchfelder, T. Kuwert, R. Linke, and O. Ganslandt Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging J. Nucl. Med., May 1, 2008; 49(5): 721 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Panigrahy, M. D. Nelson Jr, J. L. Finlay, R. Sposto, M. D. Krieger, F. H. Gilles, and S. Bluml Metabolism of diffuse intrinsic brainstem gliomas in children Neuro-oncol, February 1, 2008; 10(1): 32 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Glunde, T. Shah, P. T. Winnard Jr., V. Raman, T. Takagi, F. Vesuna, D. Artemov, and Z. M. Bhujwalla Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1{alpha} Signaling in a Human Prostate Cancer Model Cancer Res., January 1, 2008; 68(1): 172 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al. Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience Radiology, December 1, 2007; 245(3): 788 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chawla, S. Wang, R.L. Wolf, J.H. Woo, J. Wang, D.M. O'Rourke, K.D. Judy, M.S. Grady, E.R. Melhem, and H. Poptani Arterial Spin-Labeling and MR Spectroscopy in the Differentiation of Gliomas AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1683 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pinker, I.M. Noebauer-Huhmann, I. Stavrou, R. Hoeftberger, P. Szomolanyi, G. Karanikas, M. Weber, A. Stadlbauer, E. Knosp, K. Friedrich, et al. High-Resolution Contrast-Enhanced, Susceptibility-Weighted MR Imaging at 3T in Patients with Brain Tumors: Correlation with Positron-Emission Tomography and Histopathologic Findings AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1280 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Altman, D. S. Atkinson Jr, and D. J. Brat Best Cases from the AFIP: Glioblastoma Multiforme RadioGraphics, May 1, 2007; 27(3): 883 - 888. [Full Text] [PDF]
|
|
|
|
|
|
A. Stadlbauer, C. Nimsky, S. Gruber, E. Moser, T. Hammen, T. Engelhorn, M. Buchfelder, and O. Ganslandt Changes in Fiber Integrity, Diffusivity, and Metabolism of the Pyramidal Tract Adjacent to Gliomas: A Quantitative Diffusion Tensor Fiber Tracking and MR Spectroscopic Imaging Study AJNR Am. J. Neuroradiol., March 1, 2007; 28(3): 462 - 469. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
